Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 71755

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 23, 2015
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Actavis Laboratories, FL, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only. Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA; Distributed by Actavis Pharma, Inc. Parsippany, NJ 07054 USA. NDC: 0591-2464-01.

D-1285-2015
Recall number
D-1285-2015
Initiated
June 23, 2015
Classification
Class III
Status
Terminated
Quantity
11,445 Bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Code information

Lot # 982021M, Expiry: DEC. 2016

Distribution pattern

U.S. Nationwide including Puerto Rico.